Arcadia Biosciences (RKDA) Misses Q2 EPS by 326c

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($3.26). Revenue for the quarter came in at $1.45 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Eli Lilly: Q2 2026 IPR&D charge estimated at $3.02 per share on GAAP and non-GAAP basis
• First Majestic raises 2026 output guidance after Q2 silver, gold gains
• Rambus launches DDR5 9600 server RDIMM chipset for AI workloads